213 related articles for article (PubMed ID: 21123220)
1. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
[TBL] [Abstract][Full Text] [Related]
2. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.
Miller AL; Gosch K; Daugherty SL; Rathore S; Peterson PN; Peterson ED; Ho PM; Chan PS; Lanfear DE; Spertus JA; Wang TY
Am Heart J; 2013 Oct; 166(4):737-43. PubMed ID: 24093855
[TBL] [Abstract][Full Text] [Related]
3. Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry.
Boriani G; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Rauhe W; Biffi M; Santi E; Becker D; Messier M; Santini M
BMC Cardiovasc Disord; 2012 Sep; 12():72. PubMed ID: 22966862
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
Hess PL; Laird A; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Hall WJ; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Al-Khatib SM; Piccini JP; Inoue LY; Sanders GD
Heart Rhythm; 2013 Jun; 10(6):828-35. PubMed ID: 23416381
[TBL] [Abstract][Full Text] [Related]
5. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
[TBL] [Abstract][Full Text] [Related]
6. Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.
Pertzov B; Novack V; Zahger D; Katz A; Amit G
Int J Cardiol; 2013 Jun; 166(2):421-4. PubMed ID: 22100182
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
[TBL] [Abstract][Full Text] [Related]
8. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
[TBL] [Abstract][Full Text] [Related]
10. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
[TBL] [Abstract][Full Text] [Related]
11. ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction.
van Dijk VF; Quast ABE; Schaap J; Balt JC; Kelder JC; Wijffels MCEF; de Groot JR; Boersma LVA
J Cardiovasc Electrophysiol; 2020 Feb; 31(2):536-543. PubMed ID: 31944462
[TBL] [Abstract][Full Text] [Related]
12. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
13. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
[TBL] [Abstract][Full Text] [Related]
14. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
[TBL] [Abstract][Full Text] [Related]
15. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).
Santini M; Russo M; Botto G; Lunati M; Proclemer A; Schmidt B; Erdogan A; Helmling E; Rauhe W; Desaga M; Santi E; Messier M; Boriani G
Europace; 2009 Apr; 11(4):476-82. PubMed ID: 19136492
[TBL] [Abstract][Full Text] [Related]
16. Defibrillator implantation early after myocardial infarction.
Steinbeck G; Andresen D; Seidl K; Brachmann J; Hoffmann E; Wojciechowski D; Kornacewicz-Jach Z; Sredniawa B; Lupkovics G; Hofgärtner F; Lubinski A; Rosenqvist M; Habets A; Wegscheider K; Senges J;
N Engl J Med; 2009 Oct; 361(15):1427-36. PubMed ID: 19812399
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
18. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
[TBL] [Abstract][Full Text] [Related]
19. Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.
Blumer J; Wolber T; Hellermann J; Holzmeister J; Binggeli C; Duru F; Brunckhorst C
Int Heart J; 2009 May; 50(3):313-21. PubMed ID: 19506335
[TBL] [Abstract][Full Text] [Related]
20. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Piccini JP; Al-Khatib SM; Hellkamp AS; Anstrom KJ; Poole JE; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2011 Mar; 8(3):393-400. PubMed ID: 21109025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
